AFIB News and Press, Acutus Medical Inc. From 03/21/24

X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...

A look at the top 10 most actives in the United States Fisker Inc. Class A (FSR) fell 9.8% to $0.133 on volume of 209,262,975 shares Ontrak Inc. (OTRK) rose 131.6% to $0.44 on volume of 206,699,914 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 1.7% to $3.65 on volume of 1...

A look at the top 10 most actives in the United States Fisker Inc. Class A (FSR) fell 15.6% to $0.1475 on volume of 286,845,446 shares Verb Technology Company Inc. (VERB) fell 18.6% to $0.36 on volume of 244,515,000 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 0.0% to $3...

2024-01-25 07:23:53 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Pre-market stock movers are a hot topic on Thursday morning and we have all the coverage traders need to know about today. Moving stocks this morning are public offerings, earnings reports ...

2023-11-14 10:27:34 ET Acutus Medical press release ( NASDAQ: AFIB ): Q3 Non-GAAP EPS of -$0.52. Revenue of $5.2M (+44.4% Y/Y). Due to the announced plan to realign resources to support the left-heart access distribution business and exit from the electrophysiology map...

2023-11-12 06:48:07 ET Summary Stereotaxis was forced to do a human trial for its Magic catheter before it can get CE Mark. This is starting in a few weeks. Stereotaxis will soon submit a PMA for FDA approval of the Magic catheter 180 days after submission. China is set to app...

CARLSBAD, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), today announced that, following the Company’s announcement of its strategic realignment of resources and corporate restructuring and release of i...

Acutus Medical Inc. (AFIB) is expected to report $-0.57 for Q3 2023

2023-11-08 18:45:32 ET More on Acutus Medical Seeking Alpha’s Quant Rating on Acutus Medical Historical earnings data for Acutus Medical Financial information for Acutus Medical For further details see: Acutus Medical to cut 65% of workforce, focus...

2023-11-08 17:29:10 ET Acutus Medical press release ( NASDAQ: AFIB ): Q3 Non-GAAP EPS of -$0.52 beats by $0.04 . Revenue of $5.2M (+44.4% Y/Y) beats by $0.36M . Third quarter revenue of $5.2 million grew 44% year-over-year, led by strong growth in distribution ...